Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Dtg-Week'

Dtg-Week published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store
Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store
by 3vprintingstore
In the bustling city of Atlanta, fashion-forward i...
Updates on Individual and Universal HIV Treatment Strategies
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Antiretrovirals for prevention in women of childbearing age:
Antiretrovirals for prevention in women of childbearing age:
by tremblay
issues to consider. Landon Myer. We all have “is...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Basic HIV Course for Health Professionals
Basic HIV Course for Health Professionals
by megan
Session 12: Contraceptives and HIV. Learning Objec...
The Fast and The Continuous:
The Fast and The Continuous:
by bery
Dolutegravir-based Antiretroviral Therapy Achieves...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Neuropsychiatric manifestations and
Neuropsychiatric manifestations and
by Mindbender
sleep disturbances in children and adolescents ran...
Country Experience in Monitoring New
Country Experience in Monitoring New
by fauna
ARVs: Focus on Toxicity Monitoring . and Surveill...
Meg Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Clinical considerations for the
Clinical considerations for the
by helene
introduction . of . DTG. Nandita Sugandhi. ICAP at...
HIV History successes and lessons learned
HIV History successes and lessons learned
by linda
PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...
Paediatric ARV Drug Optimization 3 Review Summary report &
Paediatric ARV Drug Optimization 3 Review Summary report &
by neoiate
*\n\b...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Comparison of INSTI vs INSTI
Comparison of INSTI vs INSTI
by mediumgeneral
QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...
The SA National PMTCT Guidelines (2019)
The SA National PMTCT Guidelines (2019)
by cleminal
Outline. The ideal PMTCT pathway . Detail of new i...
Comparison of INSTI vs EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
What’s New in WHO Treatment Guidelines
What’s New in WHO Treatment Guidelines
by aaron
July 23 2018 . What We Know About Safety Signals ...
Heather Watts MD Director of HIV Prevention, Program Quality Team
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
by liane-varnes
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...
10 th International Pediatric HIV Workshop
10 th International Pediatric HIV Workshop
by faustina-dinatale
and 22. nd. International AIDS Conference . Sele...
Potential safety issue affecting women living with HIV using
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
by liane-varnes
July 24 2018 . Overview on Safety of HIV Treatmen...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
New regimen for $75 a year
New regimen for $75 a year
by tawny-fly
New pricing agreement will speed up access to gen...
Updated WHO Treatment Guidelines &
Updated WHO Treatment Guidelines &
by mitsue-stanley
Data . from other . cohorts and . regions to guid...
10 th International Pediatric HIV Workshop
10 th International Pediatric HIV Workshop
by luanne-stotts
and 22. nd. International AIDS Conference . Sele...
Projecting the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI 2020)
CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI 2020)
by miguel
AND OPPORTUNISTIC INFECTIONS. (CROI 2020). BOSTON|...